Editorial Comment to Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: Update from Japan

Toshihide Naganuma; Tatsuya Nakatani

doi:10.1111/iju.12464

Editorial Comment to Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: Update from Japan

International Journal of Urology ◽

10.1111/iju.12464 ◽

2014 ◽

Vol 21 (8) ◽

pp. 761-762

Author(s):

Toshihide Naganuma ◽

Tatsuya Nakatani

Keyword(s):

Peritoneal Dialysis ◽

Editorial Comment ◽

Clinical Strategies

Download Full-text

Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: Update from Japan

International Journal of Urology ◽

10.1111/iju.12445 ◽

2014 ◽

Vol 21 (8) ◽

pp. 755-761 ◽

Cited By ~ 7

Author(s):

Masaaki Nakayama ◽

Hiroyuki Terawaki

Keyword(s):

Peritoneal Dialysis ◽

Clinical Strategies

Download Full-text

Editorial Comment to Single site with multichannel transumbilical laparoscopic implantation of long-term peritoneal dialysis catheters: Initial clinical experience of two cases

International Journal of Urology ◽

10.1111/j.1442-2042.2011.02804.x ◽

2011 ◽

Vol 18 (8) ◽

pp. 610-611

Author(s):

Haruki Kume

Keyword(s):

Peritoneal Dialysis ◽

Editorial Comment ◽

Clinical Experience ◽

Single Site ◽

Initial Clinical Experience

Download Full-text

Reducing Cardiometabolic Risk in Peritoneal Dialysis Patients: Role of the Dialysis Solution

Journal of Diabetes Science and Technology ◽

10.1177/193229680900300629 ◽

2009 ◽

Vol 3 (6) ◽

pp. 1472-1480 ◽

Cited By ~ 21

Author(s):

Clifford J. Holmes

Keyword(s):

Peritoneal Dialysis ◽

Cardiometabolic Risk ◽

Glucose Absorption ◽

Fluid Removal ◽

Dialysis Solution ◽

Clinical Strategies ◽

Patients With Diabetes ◽

Osmotic Agent ◽

Dialysis Solutions

Peritoneal dialysis (PD) is a well-established form of therapy for stage 5 chronic kidney disease requiring renal replacement therapy. D-Glucose has been used successfully for several decades as the osmotic agent employed in dialysis solutions to achieve adequate fluid removal. The absorption of 100–200 grams of glucose per day has been suggested as potentially increasing cardiometabolic risk, particularly in patients with diabetes. Supporting and undermining evidence for this hypothesis is reviewed, with a focus on the role of glucose absorption in changes in body composition, dyslipidemia, and glycemic control in diabetic PD patients. Clinical strategies to optimize fluid removal while minimizing the metabolic impact of glucose absorption are also discussed.

Download Full-text

Scanning Electron Microscopy of Staphylococcus Epidermidis Adherence to Continuous Ambulatory Peritoneal Dialysis Catheters

Proceedings, annual meeting, Electron Microscopy Society of America ◽

10.1017/s0424820100119429 ◽

1985 ◽

Vol 43 ◽

pp. 520-521

Author(s):

William J. Lamoreaux ◽

David L. Smalley ◽

Larry M. Baddour ◽

Alfred P. Kraus

Keyword(s):

Electron Microscopy ◽

Scanning Electron Microscopy ◽

Peritoneal Dialysis ◽

Continuous Ambulatory Peritoneal Dialysis ◽

Staphylococcus Epidermidis ◽

Sterile Saline ◽

Intravascular Devices ◽

Capd Patient ◽

Scanning Electron

Infections associated with the use of intravascular devices have been documented and have been reported to be related to duration of catheter usage. Recently, Eaton et al. reported that Staphylococcus epidermidis may attach to silastic catheters used in continuous ambulatory peritoneal dialysis (CAPD) treatment. The following study presents findings using scanning electron microscopy (SEM) of S. epidermidis adherence to silastic catheters in an in vitro model. In addition, sections of polyvinyl chloride (PVC) dialysis bags were also evaluated by SEM.The S. epidermidis strain RP62A which had been obtained in a previous outbreak of coagulase-negative staphylococcal sepsis at local hospitals was used in these experiments. The strain produced surface slime on exposure to glucose, whereas a nonadherent variant RP62A-NA, which was also used in these studies, failed to produce slime. Strains were grown overnight on blood agar plates at 37°C, harvested from the surface and resuspended in sterile saline (0.85%), centrifuged (3,000 rpm for 10 minutes) and then washed twice in 0.1 M phosphate-buffered saline at pH 7.0. Organisms were resuspended at a concentration of ca. 106 CFU/ml in: a) sterile unused dianeal at 4.25% dextrose, b) sterile unused dianeal at 1.5% dextrose, c) sterile used dialysate previously containing 4.25% dextrose taken from a CAPD patient, and d) sterile used dialysate previously containing 1.5% dextrose taken from a CAPD patient.

Download Full-text